Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


GUIDELINE TITLE

Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care.

BIBLIOGRAPHIC SOURCE(S)

REFERENCES SUPPORTING THE RECOMMENDATIONS

  • Alexandrova GI, Budilovsky GN, Koval TA, Polezhaev FI, Garmashova LM, Ghendon YuZ, Romanova YR, Smorodintsev AA. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial. Vaccine 1986 Jun;4(2):114-8. PubMed


  • Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000 Feb;136(2):168-75. PubMed


  • Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998 May 14;338(20):1405-12. PubMed


  • Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Klimov A, Fukuda K. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 2000 Oct 4;284(13):1655-63. PubMed


  • Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis 1991 Feb;163(2):300-4. PubMed


  • Colombo C, Argiolas L, La Vecchia C, Negri E, Meloni G, Meloni T. Influenza vaccine in healthy preschool children. Rev Epidemiol Sante Publique 2001 Apr;49(2):157-62. PubMed


  • Eddy TS, Davies NA. The effect of vaccine on a closed epidemic of Hong Kong influenza. S Afr Med J 1970 Feb 21;44(8):214-6. PubMed


  • Edmonson K, Graham D, Warburton M. A clinical trial of influenza vaccine in Canberra. Med J Aust 1970;4:6-13.


  • Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994 Jan;169(1):68-76. PubMed


  • Feldman S, Wright PF, Webster RG, Roberson PK, Mahoney J, Thompson J, Doolittle M, Lott L, Johnson P, Christoph RC. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus. J Infect Dis 1985 Dec;152(6):1212-8. PubMed


  • Gruber WC, Belshe RB, King JC, Treanor JJ, Piedra PA, Wright PF, Reed GW, Anderson E, Newman F. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst [trunc]. J Infect Dis 1996 Jun;173(6):1313-9. PubMed


  • Gruber WC, Taber LH, Glezen WP, Clover RD, Abell TD, Demmler RW, Couch RB. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child 1990 May;144(5):595-600. PubMed


  • Hammond ML, Ferris AA, Faine S, McAvan T. Effective protection against influenza after vaccination with subunit vaccine. Med J Aust 1978 Mar 25;1(6):301-3. PubMed


  • Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Huson L, Ward P, Mills RG. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999 Oct 28;341(18):1336-43. PubMed


  • Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliot MJ, Hammond JM, Sharp SJ, Ossi MJ. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med 2000 Nov 2;343(18):1282-9. PubMed


  • Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, Kinnersley N, Mills RG, Ward P, Straus SE. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999 Oct 6;282(13):1240-6. PubMed


  • Hobson D, Baker FA, Chivers CP, Reed SE, Sharp D. A comparison of monovalent Hong Kong influenza virus vaccine with vaccines containing only pre-1968 Asian strains in adult volunteers. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines. J Hyg (Lond) 1970 Sep;68(3):369-78. PubMed


  • Hoskins TW, Davies JR, Allchin A, Miller CL, Pollock TM. Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain. Lancet 1973 Jul 21;2(7821):116-20. PubMed


  • Hurwitz ES, Haber M, Chang A, Shope T, Teo ST, Giesick JS, Ginsberg MM, Cox NJ. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis 2000 Oct;182(4):1218-21. PubMed


  • Kaiser L, Henry D, Flack NP, Keene O, Hayden FG. Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study. Clin Infect Dis 2000 Mar;30(3):587-9. PubMed


  • Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988 Feb;127(2):353-64. PubMed


  • Khan AS, Polezhaev F, Vasiljeva R, Drinevsky V, Buffington J, Gary H, Sominina A, Keitel W, Regnery H, Lonskaya NL, Doroshenko E, Gavrilov A, Ivakhov I, Arden N, Schonberger LB, Couch R, Kendal A, Cox N. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren. J Infect Dis 1996 Feb;173(2):453-6. PubMed


  • Leibovitz A, Coultrip RL, Kilbourne ED, Legters LJ, Smith CD, Chin J, Schulman JL. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees. J Infect Dis 1971 Nov;124(5):481-7. PubMed


  • Mair HJ, Sansome DA, Tillett HE. A controlled trial of inactivated monovalent influenza A vaccines in general practice. J Hyg (Lond) 1974 Oct;73(2):317-27. PubMed


  • Maynard JE, Dull HB, Hanson ML, Feltz ET, Berger R, Hammes L. Evaluation of monovalent and polyvalent influenza vaccines during an epidemic of type A2 and B influenza. Am J Epidemiol 1968 Jan;87(1):148-57. PubMed


  • Mixeu MA, Vespa GN, Forleo-Neto E, Toniolo-Neto J, Alves PM. Impact of influenza vaccination on civilian aircrew illness and absenteeism. Aviat Space Environ Med 2002 Sep;73(9):876-80. PubMed


  • Monto AS, Miller FD, Maassab HF. Evaluation of an attenuated, cold-recombinant influenza B virus vaccine. J Infect Dis 1982 Jan;145(1):57-64. PubMed


  • Monto AS, Pichichero ME, Blanckenberg SJ, Ruuskanen O, Cooper C, Fleming DM, Kerr C. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. J Infect Dis 2002 Dec 1;186(11):1582-8. PubMed


  • Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 2001 Aug;20(8):733-40. PubMed


  • Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995 Oct 5;333(14):889-93. PubMed


  • Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, Glezen WP, Wittes J. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999 Jul 14;282(2):137-44. PubMed


  • Powers DC, Smith GE, Anderson EL, Kennedy DJ, Hackett CS, Wilkinson BE, Volvovitz F, Belshe RB, Treanor JJ. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. J Infect Dis 1995 Jun;171(6):1595-9. PubMed


  • Rudenko LG, Slepushkin AN, Monto AS, Kendal AP, Grigorieva EP, Burtseva EP, Rekstin AR, Beljaev AL, Bragina VE, Cox N, et al.. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis 1993 Oct;168(4):881-7. PubMed


  • Rytel MW, Jackson LJ, Niebojewski RA, Haagensen JL, Rosenkranz MA. Field trial of live attenuated influenza A/B ("Alice"/R-75) vaccine. Am J Epidemiol 1977 Jan;105(1):49-55. PubMed


  • Tannock GA, Bryce DA, Hensley MJ, Saunders NA, Gillett RS, Kennedy WS. Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population. Vaccine 1984 Mar;2(1):100-6. PubMed


  • Waldman RH, Coggins WJ. Influenza immunization: field trial on a university campus. J Infect Dis 1972 Sep;126(3):242-8. PubMed


  • Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, Jackson HC, Huson L, Ward P, Oxford JS. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001 Feb 14;285(6):748-54. PubMed


  • Wesselius-de Casparis A, Masurel N, Kerrebijn KF. Field trial with human and equine influenza vaccines in children: protection and antibody titres. Bull World Health Organ 1972;46(2):151-7. PubMed


  • Williams MC, Davignon L, McDonald JC, Pavilanis PV, Boudreault A, Clayton AJ. Trials of aqueous killed influenza vaccine in Canada, 1968-69. Bull World Health Organ 1973;49(4):333-40. PubMed


© 1998-2009 National Guideline Clearinghouse

Date Modified: 2/16/2009

 

 

   
DHHS Logo